CME GROUP INC. CME

CME Group's current file is led by official SEC activity rather than a fresh promotional story: the evidence names a 2026-06-17 8-K, a 2026-06-10 8-K, a 2026-05-19 DEFA14A, a 2026-05-19 Form 4, a 2026-05-19 8-K and a 2026-05-18 Form 144. The 2026-06-17 8-K rail says CME Group Inc. announced that Terrence A, but the supplied extract stops there, so the responsible read is limited to the existence of the official filing and the partial announcement text.

CME Group Inc. is being treated here as an equity story built around an operating exchange and market infrastructure business, not as a loose market mood. The evidence does not supply product launch details, customer counts, trading volumes or segment data. What it does supply is the official SEC rail, which is enough to anchor the report in filings, cash, income and the machinery of public-company disclosure.

The latest filed financial facts in the supplied SEC EDGAR evidence show revenues of $1.88B and operating income of $1.31B in the 10-Q for the period ending 2026-03-31. The same 10-Q rail gives assets of $201.99B, liabilities of $175.38B, stockholders' equity attributable to the parent of $26.62B, cash and cash equivalents at carrying value of $2.39B, net cash provided by operating activities of $1.26B, payments to acquire property, plant and equipment of $21.8M, diluted earnings per share of $3.18 and weighted average diluted shares outstanding of 363.2M. The supplied 10-K fact for the period ending 2025-12-31 gives net income attributable to the parent of $4.07B.

The chart rail is not supplied as a named source route, so this report does not invent candles, levels, moving averages or price action. The market mechanism that can be discussed from the evidence is narrower and cleaner: CME is a listed operating business with an SEC filing trail, reported quarterly revenue and operating income, a large asset and liability base, and public disclosures that can change the file when the full text is available.

The 2026-05-19 DEFA14A adds a governance and proxy-process angle rather than an earnings one. Its supplied text says the definitive proxy statement and other relevant materials, when they become available, plus other CME Group SEC documents, may be obtained free of charge at the SEC website. That is procedural, but procedure matters in an equity file because public-company control, voting materials and official disclosures are part of the instrument's information supply.

What remains unproved is just as important as what is filed. The evidence does not provide current share price, valuation, volume, guidance, dividend, buyback detail, trading-volume mix, segment pressure, lawsuit context or a complete reading of the 2026-06-17 Terrence A announcement. The deeper file would need the full named filings parsed in detail, plus any official earnings release or presentation if supplied on the same source rail.